Gene Query: MED6

Dataset Description Geneva Score
Cleavage Factor Im as a key regulator of 3’ UTR length 26.2
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 18.69
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 13.69
DUX4-induced dsRNA and MYC mRNA Stabilization Activate Apoptotic Pathways in Human Cell Models of Facioscapulohumeral Dystrophy 13.46
A transcriptome-wide divergence in protein translation scales with LIN28B expression 12.74
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 11.46
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 10.68
Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells 10.39
MYCi975 regulates MYC target genes 9.81
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 9.38
8.87
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 8.85
The regulartory role of ZCCHC24 in splicing machinery 8.58
Identification of transcription start sites for human A549 cell line using ReCappable-seq 7.46
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 7.44
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 7.36
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 7.2
scRNASeq analysis of cycling cardiomyocytes 7.02
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 6.82
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 6.59
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 6.55
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 6.5
Mouse Dux is myotoxic and shares partial functional homology with its human paralog DUX4 6.45
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 6.44
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 6.37
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 6.29
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 6.24
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 6.16
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 6.06
Histone Demethylase-Assisted Somatic Cell Nuclear Transfer Facilitates Derivation of Human Pluripotent Stem Cells 5.95
Genome wide expression change by RNF168 knocking down in MCF-7 cells 5.9
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 5.89
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 5.83
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 5.74
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 5.74
Effect of disulfiram treatment on pediatric high grade glioma 5.56
Nucleoporin-mediated regulation of cell identity genes 5.54
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 5.4
Overexpression and knockdown experiment for circCSNK1G3 5.27
SLAM-seq for K562 endogenous mRNA decay 5.19
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 5.01
mRNA expression profile of Lymphocytes 5.0
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 4.93
Generating Patterned Kidney Organoids for Studying Development and Diseases 4.88
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 4.87
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 4.77
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 4.64
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 4.64
CROP-Seq in Primary Human T Cells 4.64
mRNA expression in iPS cells generated by a synthetic self-replicative RNA 4.52
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 4.5
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 4.43
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 4.37
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 4.31
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 4.25
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 4.21
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer 4.17
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. 4.17
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 4.14
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 4.06
FBXW7 modulates stress response by post-translational modification of HSF1 4.06
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 4.05
A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression and cell death 4.0
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 3.99
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 3.98
To investigate the decay constants (half-lives) of transcript isoforms generated by alternative polyadenylation in proliferating and quiescent cells 3.97
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 3.94
Differentially expressed genes post knock down of lincDUSP26 3.88
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 3.88
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 3.88
Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer 3.74
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 3.73
Co-transcriptional loading of RNA export factors shapes the human transcriptome 3.73
RNAseq of HEK293 cells after Chtop knockdown 3.73
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 3.7
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 3.7
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 3.66
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 3.63
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 3.62
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 3.62
Unique features and clinical importance of acute alloreactive immune responses 3.6
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 3.6
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 3.6
Conservative alteration of chromosomal expression pattern across human solid tumor types 3.53
Paxillin regulates genomic networks in prostate cancer [PC3] 3.5
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 3.46
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 3.45
High-resolution comparative analysis of great ape genomes 3.43
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 3.43
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 3.43
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 3.42
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 3.32
Seletive inhibition of CDK9 in DLBCL cell lines 3.29
Integrating single-cell transcriptomic data across different conditions, technologies, and species 3.27
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 3.27
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 3.25
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 3.24
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 3.24
RNA sequencing for PDX1, NGN3 and MAFA transduced iPSCs cell 3.21
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 3.21
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 3.21
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 3.18
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 3.18
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 3.16
RNA-seq of YB5 cells treated with Proscillaridin A 3.14
Generation and persistence of human tissue-resident memory T cells in lung transplantation 3.13
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 3.09
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 3.09
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 3.07
Gene expression signatures of innate lymphoid cells from human blood 3.02
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 2.99
Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify 2.97
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 2.95
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 2.95
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 2.94
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 2.93
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 2.93
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 2.92
Genome wide mapping of polyadenylation sites in proliferating and contact-inhibited cells and cells with knockdown of cleavage and polyadenylation factors 2.92
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 2.91
C9orf72 Intermediate Repeats are Associated with Corticobasal Degeneration, Increased C9orf72 Expression and Disruption of Autophagy 2.91
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 2.88
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 2.86
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 2.86
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 2.86
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 2.85
Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development 2.83
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 2.82
Developmental stage specific chromosome architecture in human erythroid cells 2.82
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 2.79
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 2.78
Identification of a LIF-responsive replication-competent human β cell 2.78
Quantitative Analysis of PPARD Transcriptomes in Colon Cancer Cells by Next Generation Sequencing (NGS) 2.77
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 2.74
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 2.74
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 2.72
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 2.72
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 2.7
Transcriptome analysis of U87 cells upon LINC00152 knockdown 2.69
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 2.67
Transcriptome-wide identification of CELF2 functional targets in T cells 2.67
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 2.67
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 2.67
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 2.66
Patient-derived luminal breast cancer xenografts with progestins 2.66
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 2.66
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 2.64
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 2.63
A Unique Epigenomic Landscape Defines Human Erythropoiesis 2.61
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 2.61
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 2.57
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 2.54
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 2.53
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 2.52
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 2.52
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 2.52
HNF1A deficiency impairs β-cell fate, granule maturation and function 2.52
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 2.49
Genome wide expression change by RNF168 knocking down in NEC cells 2.48
Global Mapping of Human RNA-RNA Interactions 2.48
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 2.48
Mutational landscape of splicing genes and functional consequences across 33 cancer types 2.41
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 2.4
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 2.39
Effect of from Human Umbilical Vein Endothelial Cells 2.37
Control of prostate tumour growth by the long non-coding RNA GHSROS 2.35
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 2.34
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 2.33
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 2.32
SNHG5 siRNA knock down in HCT116 cells 2.32
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 2.32
U1 snRNP telescripting regulates size-function stratified human genome 2.32
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 2.32
RNA-Sequencing experiment for effects of PKF115-584 treatment on four T-ALL cell lines (RPMI8402, HPB-ALL, Jurkat, CCRF-CEM). 2.29
Impact of dieldrin on transcription in Jurkat T cells 2.29
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 2.28
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 2.27
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 2.27
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO 2.25
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 2.25
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 2.22
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 2.22
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 2.22
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 2.22
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 2.22
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 2.21
Oncogenic changes and EMT in normal human bile duct epithelial cells are caused by parasite-derived materials and N-nitrosodimethylamine 2.21
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 2.2
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis 2.2
Effect of BB608 on Gene Expression in HNSCC Cell Line 2.17
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 2.1
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 2.1
Identification of renal resident macrophages across species 2.07
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 2.06
A549 cells and MSR-A549 cells 2.03
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 2.03
R430: A potent inbibitor of DNA and RNA viruses 2.03
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression (RNA-seq) 2.02
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression 2.02
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 2.01
HEXIM1 is induced by DHODH inhibition to suppress melanoma 1.97
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 1.97
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 1.97
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 1.96
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 1.96
Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes 1.95
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 1.95
Integrin signaling regulates YAP/TAZ to control skin homeostasis 1.95
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 1.94
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 1.93
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 1.91
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 1.91
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 1.9
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 1.88
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 1.88
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 1.88
Functional role of CPPED1 in trophoblasts. 1.87
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 1.85
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 1.85
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 1.83
Comprehensive analysis of microRNA expression in regionalized human neural progenitor cells reveals microRNA-10 as a caudalizing factor 1.81
Downregulation of DDX5/DDX17 and REST 1.8
SLIGRL-induced gene expression changes in NHEK cells 1.77
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing 1.75
Transcriptome of human ILC2s; primary vs IL-1b-primed 1.74
FOXP3 protects conventional human T cells from premature restimulation-induced cell death 1.72
Cajal bodies are linked to genome conformation [RNA-Seq] 1.71
Cajal bodies are linked to genome conformation 1.71
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 1.7
Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing 1.7
Epigenetic reprogramming of melanoma cells by vitamin C treatment 1.68
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 1.68
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 1.67
Gene expression profile in breast cancer cells 1.66
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 1.66
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 1.65
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 1.64
RNA sequencing of human mammary epithelial cells 1.64
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 1.64
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 1.64
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 1.64
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 1.64
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 1.63
Transcriptomics profiling of Alzheimer’s disease reveal novel molecular targets 1.62
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 1.6
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 1.6
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 1.6
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 1.58
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 1.58
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 1.57
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 1.57
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 1.57
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 1.57
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 1.55
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 1.55
Silencing p300 in MCF7 cells to study expression and alternative splicing 1.52
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 1.49
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 1.47
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 1.47
LIN28A modulates splicing and gene expression programs in breast cancer cells 1.47
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 1.47
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 1.46
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 1.45
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 1.44
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers 1.42
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers (RNA-Seq) 1.42
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 1.42
Human serum and heparin-free platelet lysate as appropriate xeno-free alternatives for production of human MuStem cell batches 1.41
Hypoxic transcriptome of SQ20B human head and neck cancer cells 1.41
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 1.38
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 1.38
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 1.36
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 1.36
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 1.35
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 1.34
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 1.33
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration 1.32
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  1.32
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 1.32
Expression alterations induced by restoration of AXIN1 expression in SNU449 hepatocellular carcinoma cells 1.31
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 1.3
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 1.29
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 1.29
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 1.28
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 1.28
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 1.28
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 1.28
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 1.28
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 1.27
Targeted differentiation of regional ventral neuroprogenitors and related neuronal subtypes from human pluripotent stem cells 1.27
Simultaneous and systematic analysis of cellular and viral gene expression during Enterovirus 71-induced host shutoff 1.27
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown 1.27
RNA-seq analysis of differentiating human erythroblasts 1.25
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 1.24
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 1.23
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 1.23
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 1.23
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 1.22
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 1.21
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 1.19
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 1.19
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 1.19
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 1.18
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 1.17
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 1.17
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 1.16
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 1.15
Genome-wide analysis of the Integrator complex 1.15
Genome-wide analysis of the Integrator complex (HTS) 1.15
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 1.12
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 1.12
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 1.11
Real-time observation of light-controlled transcription in living cells 1.1
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 1.1
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 1.09
Transcriptional landscape changes during human embryonic stem cell derivation 1.09
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 1.08
Discovering human diabetes-risk gene function with genetics and physiological assays 1.07
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 1.07
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 1.07
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 1.06
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 1.05
single cell RNA-seq from GM12878 (ENCSR673UIY) 1.05
An optimization system for isolating and sequencing of single human colon cancer cells 1.05
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 1.04
Ribosomal protein RPL26 is the principal target of UFMylation 1.04
Novel Non-catalytic Substrate-selective p38α-specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-inflammatory Activity 1.02
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 1.02
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 1.02
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 1.01
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 1.01
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 1.0
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 0.98
RNA-Seq with and without RNase treatment in PCa cell lines 0.98
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 0.97
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 0.97
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 0.95
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 0.94
Total RNA-seq in ALL-SIL upon TLX1 knockdown 0.93
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways 0.93
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 0.91
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 0.91
Human Treg NaCl stimulation 0.9
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 0.89
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 0.88
Expression profiling of MCF-7 cells with treatment of TCDD 0.88
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 0.88
Role of FGFR1 in neuronal devlopment 0.86
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 0.85
Transcriptional response of human endocervical epithelial A2EN cells to infection with wild-type or CpoS-deficient Chlamydia trachomatis L2/434/Bu 0.85
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 0.85
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 0.85
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 0.84
Functional significance of the HIV-1 Tat signature amino acid residues 0.83
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 0.83
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 0.81
P120-catenin dependent glioma-cell networks drive growth and diffuse brain infiltration 0.81
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 0.8
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 0.8
Analyses of T-ALL (COG study) 0.8
RNA sequencing of T-ALL (COG study) 0.8
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 0.8
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 0.8
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 0.79
Effect of drugs on transcriptomic profiles 0.79
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 0.78
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 0.77
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 0.76
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 0.76
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 0.74
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 0.72
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 0.72
ETV7 and interferon response 0.71
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 0.71
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 0.71
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 0.7
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 0.7
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 0.69
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 0.69
Systematic discovery of endogenous human ribonucleoprotein complexes 0.68
mRNA expression profile of Lymphocytes by high-throuput sequencing 0.67
A20 regulates canonical wnt-signaling through an interaction with RIPK4 0.66
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 0.66
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 0.65
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 0.65
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 0.64
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 0.64
Gene expression comparison of resting human peripheral-blood NK cells and activated counterparts 0.63
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 0.63
p53 activity results in DNA replication fork processivity 0.62
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 0.62
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.6
p63 controls the enhancer landscape during keratinocyte differentiation 0.6
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 0.59
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 0.58
Transcriptome of melanoma cell lines resistant to inhibition of the MAPK pathway. 0.58
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 0.57
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 0.57
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 0.56
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 0.55
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 0.55
RNA expression analysis upon JMJD1C depletion 0.55
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 0.55
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 0.55
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 0.52
Role of COP1 on MAP kinase transcriptional output in melanoma 0.52
Genome-wide effect of inhibition of glutamine transporter ASCT2 in PC-3 cells by BenSer or GPNA 0.5
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 0.48
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.48
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 0.47
Impact on erythroid progenitor type on erythroid differntiation 0.47
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 0.47
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 0.47
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 0.46
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 0.46
Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin 0.44
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 0.44
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 0.43
MAIT cell RNA sequencing 0.42
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 0.42
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 0.42
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 0.42
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 0.41
RNA-sequencing analysis of CD4 T cells following ipilimumab therapy 0.41
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 0.39
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 0.39
microRNAs with an AAGUGC seed motif constitute an integral part of a signaling network driving NSCLC cell proliferation 0.39
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 0.39
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 0.37
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 0.37
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 0.37
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 0.35
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 0.35
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 0.34
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 0.33
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 0.33
Effect of PRDM11 depletion in U2932 cells 0.33
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 0.32
Myc activation coordinates gene transcription and protein translation responses 0.32
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 0.3
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures 0.3
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 0.29
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 0.26
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  0.26
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 0.26
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 0.26
Folate modulation induces chromosomal instability and higher proliferation of immortalized human keratinocytes 0.26
Single-cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils 0.25
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 0.24
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 0.23
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.23
Human Treg IFNg/IL-10 subpopulations 0.23
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis [RNA-Seq_Hs] 0.23
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis 0.23
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.22
HBEC-shp53-PCHD7 0.19
siRNA-mediated knockdown 0.18
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 0.18
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 0.18
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 0.18
Mutational landscape of aggressive natural killer-cell leukemia and drug profiling highlight JAK-STAT signaling as a therapeutic target in NK-cell malignancies 0.16
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.16
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 0.15
Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells 0.15
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 0.13
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 0.13
4sUDRB-seq: measuring transcription elongation and initiation genomewide 0.13
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 0.13
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 0.13
Leucegene: AML sequencing (part 6) 0.12
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 0.12
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 0.11
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 0.11
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 0.11
Transcriptome-wide modulation of splicing by the exon junction complex 0.11
Single-cell analysis of adult human ovary using 10X genomics 0.11
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 0.1
Investigate A2M treatment on human prostate cancer xenograft in mice 0.1
Investigate A2M treatment on human prostate cancer and mouse liver 0.1
Function and hormonal regulation of GATA3 in human first trimester placentation 0.1
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 0.09
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 0.09
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 0.08
RNA-seq data 0.07
Aging-associated patterns in the expression of human endogenous retroviruses 0.07
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.06
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 0.06
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.06
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 0.05
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 0.05
MARS Seq data from human cortical organoids 0.05
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.04
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 0.02
Comprehensive comparative analysis of 5’ end RNA sequencing methods 0.02
Interleukin-1β induces mitochondrial DAMP production to activate STING-dependent innate immune programs 0.01
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 0.01
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 0.01
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 0.01
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.0
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation